首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 核酸药物

市场调查报告书

商品编码

1609713

2025-2033 年日本胜肽治疗市场报告（按类型、製造商类型、合成技术、给药途径、应用和地区）

Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年日本胜肽治疗IMARC Group规模达25.927亿美元。对快速、精确的糖尿病治疗方法的需求日益增长，以及人们越来越倾向于透过整容手术来减轻皮肤老化的影响，这主要推动了市场的成长。

胜肽是高效且特异的讯号分子，可附着在特定细胞表面受体（包括离子通道和 G 蛋白偶联受体 (GPCR)）上，启动细胞内反应。在製药领域，它们被用来开发创新的再生疗法，能够针对各种类型的细胞并影响其反应。与其他治疗替代方案相比，这些疗法毒性较小，通常安全且耐受性良好。因此，它们在日本各地的临床应用中越来越受欢迎，用于治疗癌症、损伤、传染病、代谢紊乱和美学问题等疾病。

日本胜肽治疗市场趋势：

急性和慢性疾病的盛行率不断上升，加上医疗服务的改善，是对创新疗法开发中对胜肽的需求产生积极影响的一个突出因素，这主要推动了市场的成长。此外，胜肽也用于药妆过程中以减轻皮肤老化的影响。再加上人们对自己外表的认识不断增强，以及保持皮肤年轻和健康的愿望，正在推动美容治疗和基于胜肽的疗法在全球范围内的采用。此外，新合成技术的引入减少了注射频率并增强了胜肽治疗剂的稳定性和其他物理属性，这使得它们在糖尿病患者的注射中广泛使用。再加上糖尿病发生率的增加以及对快速、精确治疗方法的偏好，正在推动肽疗法相对于口服药物的使用。此外，个人化和标靶治疗的新兴趋势正在推动对多功能肽基材料的需求，这是另一个重要的生长诱导因素。除此之外，对开发用于自体免疫和发炎性疾病的新型胜肽疗法的投资不断增加，预计将在未来几年创造有利的市场前景。

日本胜肽治疗市场细分：

类型见解：

创新的
通用的

製造商洞察类型：

外包
内部

合成技术见解：

固相胜肽合成
液相胜肽合成
混合技术

管理见解的途径：

注射用
口服
其他的

应用见解：

胃肠道疾病
神经系统疾病
代谢紊乱
癌症
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本胜肽治疗市场迄今表现如何，未来几年将如何表现？
COVID-19 对日本胜肽治疗市场有何影响？
日本肽治疗市场按类型划分是怎样的？
日本肽治疗市场按製造商类型划分是怎样的？
基于合成技术的日本胜肽治疗市场的细分是什么？
日本肽治疗市场依给药途径划分是怎样的？
日本肽治疗市场的应用如何？
日本肽治疗市场价值链的各个阶段是什么？
日本肽疗法的关键驱动因素和挑战是什么？
日本胜肽治疗市场的结构如何？
日本肽治疗市场的竞争程度如何？

本报告回答的关键问题：

日本胜肽治疗市场迄今表现如何，未来几年将如何表现？
COVID-19 对日本胜肽治疗市场有何影响？
日本肽治疗市场按类型划分是怎样的？
日本肽治疗市场按製造商类型划分是怎样的？
基于合成技术的日本胜肽治疗市场的细分是什么？
日本肽治疗市场依给药途径划分是怎样的？
日本肽治疗市场的应用如何？
日本肽治疗市场价值链的各个阶段是什么？
日本肽疗法的关键驱动因素和挑战是什么？
日本胜肽治疗市场的结构如何？
日本肽治疗市场的竞争程度如何？

固相胜肽合成
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
液相胜肽合成
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
混合技术
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 9 章：日本胜肽治疗市场 - 细分：依给药途径分类

注射用
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
口服
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 10 章：日本胜肽治疗市场 - 细分：按应用分类

胃肠道疾病
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
神经系统疾病
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
代谢紊乱
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
癌症
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
其他的
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 11 章：日本胜肽治疗市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 12 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 13 章：日本胜肽治疗市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 14 章：附录

简介目录

Product Code: SR112024A18531

Japan peptide therapeutics market size reached USD 2,592.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,776.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.37% during 2025-2033. The inflating need for fast and precise treatment methods to cure diabetes, along with the increasing inclination among individuals towards cosmetic procedures to mitigate the effects of skin aging, is primarily driving the market growth.

Peptides are highly effective and specific signaling molecules that attach to particular cell surface receptors, including ion channels and G protein-coupled receptors (GPCRs), initiating intracellular responses. In the pharmaceutical sector, they are utilized to develop innovative regenerative therapies capable of targeting various types of cells and influencing their reactions. These therapies, in comparison to other treatment alternatives, are less toxic, generally safe, and well-tolerated. Consequently, they are becoming increasingly popular in clinical applications throughout Japan for the treatment of conditions such as cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Japan Peptide Therapeutics Market Trends:

The increasing prevalence of both acute and chronic illnesses, alongside improved access to medical services, stands as a prominent factor that is positively impacting the demand for peptides in the development of innovative therapies, which is primarily driving the market growth. Additionally, peptides are employed in cosmeceutical procedures to mitigate the effects of skin aging. This, combined with the growing awareness among individuals about their physical appearance and the desire to maintain youthful and healthy skin, is propelling the adoption of cosmetic treatments and peptide-based therapeutics worldwide. Furthermore, the introduction of new synthetic techniques that reduce the frequency of injections and enhance the stability and other physical attributes of peptide therapeutics has led to their widespread use in injections for diabetic patients. This, in conjunction with the increasing incidence of diabetes and a preference for rapid and precise treatment methods , is driving the utilization of peptide therapeutics over oral medications. Moreover, the emerging trend of personalized and targeted therapies is driving the demand for versatile peptide-based materials, which is acting as another significant growth-inducing factor. Alongside this, the growing investment in the development of novel peptide therapeutics for autoimmune and inflammatory conditions is expected to create a favorable market outlook in the coming years.

Japan Peptide Therapeutics Market Segmentation:

Type Insights:

Innovative
Generic

Type of Manufacturer Insights:

Outsourced
In-house

Synthesis Technology Insights:

Solid Phase Peptide Synthesis
Liquid Phase Peptide Synthesis
Hybrid Technology

Routes of Administration Insights:

Parenteral
Oral
Others

Application Insights:

Gastrointestinal Disorders
Neurological Disorders
Metabolic Disorders
Cancer
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan peptide therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan peptide therapeutics market?
What is the breakup of the Japan peptide therapeutics market on the basis of type?
What is the breakup of the Japan peptide therapeutics market on the basis of type of manufacturer?
What is the breakup of the Japan peptide therapeutics market on the basis of synthesis technology?
What is the breakup of the Japan peptide therapeutics market on the basis of routes of administration?
What is the breakup of the Japan peptide therapeutics market on the basis of application?
What are the various stages in the value chain of the Japan peptide therapeutics market?
What are the key driving factors and challenges in the Japan peptide therapeutics?
What is the structure of the Japan peptide therapeutics market and who are the key players?
What is the degree of competition in the Japan peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Peptide Therapeutics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Peptide Therapeutics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Peptide Therapeutics Market - Breakup by Type

6.1 Innovative
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Generic
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Peptide Therapeutics Market - Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 In-house
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Peptide Therapeutics Market - Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Hybrid Technology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Peptide Therapeutics Market - Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Peptide Therapeutics Market - Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Neurological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Metabolic Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Cancer
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)

11 Japan Peptide Therapeutics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Peptide Therapeutics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis